Study explains why many cancer drugs fail during clinical trials
Cancer drugs often don't behave as expected in clinical trials. A study published Oct. 11 in the journal Cell Chemical Biology explores why drugs under development are unlikely to work due to insufficient genetic analysis.
Oct 25, 2023
0
41